Oncology Solutions
Biomarker Discovery and Molecular Profiling
Biomarker discovery and molecular profiling are essential components of preclinical development, providing critical insights into disease mechanisms, treatment response, and patient stratification. By identifying molecular signatures and predictive biomarkers, researchers...
Biomarker Discovery and Molecular Profiling
Biomarker discovery and molecular profiling are essential components of preclinical development, providing critical insights into disease mechanisms, treatment response, and patient stratification. By identifying molecular signatures and predictive biomarkers, researchers...
Metastatic Cancer Models
Metastatic cancer models are crucial for studying tumor progression, immune system interactions, and drug resistance in cancers that spread beyond the primary tumor site. These models help in evaluating: 1)...
Metastatic Cancer Models
Metastatic cancer models are crucial for studying tumor progression, immune system interactions, and drug resistance in cancers that spread beyond the primary tumor site. These models help in evaluating: 1)...
Genetically engineered mouse models
Genetically engineered mouse models (GEMMs) are invaluable in preclinical oncology research for their ability to faithfully recapitulate the genetic and molecular landscape of human cancers. These models enable the spontaneous...
Genetically engineered mouse models
Genetically engineered mouse models (GEMMs) are invaluable in preclinical oncology research for their ability to faithfully recapitulate the genetic and molecular landscape of human cancers. These models enable the spontaneous...
Syngeneic Models
Syngeneic mouse models are preclinical tumor models in which mouse-derived cancer cells are implanted into immunocompetent, genetically identical mice (same strain). These models are particularly valuable for studying immuno-oncology therapies...
Syngeneic Models
Syngeneic mouse models are preclinical tumor models in which mouse-derived cancer cells are implanted into immunocompetent, genetically identical mice (same strain). These models are particularly valuable for studying immuno-oncology therapies...
CDX Models
Cell line-derived xenograft (CDX) models are a cornerstone of oncology drug development, offering a robust and reproducible platform to evaluate the in vivo efficacy of anti-cancer therapies. By implanting well-characterized...
CDX Models
Cell line-derived xenograft (CDX) models are a cornerstone of oncology drug development, offering a robust and reproducible platform to evaluate the in vivo efficacy of anti-cancer therapies. By implanting well-characterized...
PDX Models
At MuriPhys, we provide comprehensive preclinical oncology solutions to support the development of novel cancer therapeutics. We offer patient-derived xenografts (PDX), orthotopic tumor models, and advanced drug administration techniques that ensure...
PDX Models
At MuriPhys, we provide comprehensive preclinical oncology solutions to support the development of novel cancer therapeutics. We offer patient-derived xenografts (PDX), orthotopic tumor models, and advanced drug administration techniques that ensure...
Radiopharmaceutical Research
Radiopharmaceutical research is revolutionizing the way we diagnose and treat diseases, particularly in oncology. By harnessing radioactive isotopes for both imaging and targeted therapy, this field enables precision medicine approaches...
Radiopharmaceutical Research
Radiopharmaceutical research is revolutionizing the way we diagnose and treat diseases, particularly in oncology. By harnessing radioactive isotopes for both imaging and targeted therapy, this field enables precision medicine approaches...
TALK TO A SCIENTIST TODAY
MURIPHYS SOLUTIONS
Partner with Muriphys to drive innovation in your research.